This content is from: Patents

China’s Supreme People’s Court consults on evidence admissibility in patent validity proceedings

We spoke to lawyers in China to ask what the guidelines mean for patent litigation, especially in chemical/pharmaceutical cases

Get Free Access to read more …

To read the full article, activate your free trial.

Get Free Access
  • Unlimited articles for one week
  • No commitments; no payment details required
  • Featuring IP strategy, copyright, patents, trademark and more!

Are you a Managing IP subscriber? Simply login here.